Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-056980
Filing Date
2025-04-23
Accepted
2025-04-23 08:45:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa_14a_2025.htm DEFA14A 19864
2 GRAPHIC img139653605_0.jpg GRAPHIC 512153
3 GRAPHIC img139653605_1.jpg GRAPHIC 342830
  Complete submission text file 0000950170-25-056980.txt   1198058
Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42272 | Film No.: 25859332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)